Publications

  1. Xie H, Liu J, Ogden JR, Yin J, Jatoi A, Hubbard JM, McWilliams RR, Mahipal A, Petersen GM, Bekaii-Saab TS, Ma WW. Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma. Am J Clin Oncol. 2020 Aug; 43 (8):586-590
    View PubMed
  2. Sheehan MT, Wermers RA, Jatoi A, Loprinzi CL, Onitilo AA. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Med Hypotheses. 2020 Jul 30; 143:110149 Epub 2020 July 30
    View PubMed
  3. Xie H, Liu J, Yin J, Ogden JR, Mahipal A, McWilliams RR, Truty MJ, Bekaii-Saab TS, Petersen GM, Jatoi A, Hubbard JM, Ma WW. Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma. Oncologist. 2020 Jul 14 Epub 2020 July 14
    View PubMed
  4. Antwi SO, Bamlet WR, Rabe KG, Cawthon RM, Umudi I, Druliner BR, Sicotte H, Oberg AL, Jatoi A, Boardman LA, Petersen GM. Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2020 Jul; 29 (7):1492-1500 Epub 2020 Apr 20
    View PubMed
  5. Narasimhulu DM, McGree ME, Weaver AL, Jatoi A, LeBrasseur NK, Glaser GE, Langstraat CL, Block MS, Kumar A. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer. Gynecol Oncol. 2020 Jun 6 Epub 2020 June 06
    View PubMed
  6. Stout J, Kumbamu A, Tilburt J, Fernandez C, Geller G, Koenig B, Lenz HJ, Jatoi A. Conversations on Cancer Chemotherapy Cessation in Patients With Advanced Cancer: Qualitative Findings From a Multi-Institutional Study. Am J Hosp Palliat Care. 2020 Jun 4; 1049909120930710 Epub 2020 June 04
    View PubMed
  7. Cathcart-Rake E, O'Connor JM, Ridgeway JL, Breitkopf CR, Guire LJM, Olson EA, Kaur JS, Leventakos K, Jatoi A. Querying Patients With Cancer About Sexual Health and Sexual and Gender Minority Status: A Qualitative Study of Health-Care Providers. Am J Hosp Palliat Care. 2020 Jun; 37 (6):418-423 Epub 2019 Oct 10
    View PubMed
  8. Piderman KM, Radecki Breitkopf C, Jenkins SM, Ingram C, Sytsma TT, Lapid MI, Tata BS, Chatterjee K, Egginton JS, Jatoi A. Hearing and Heeding the Voices of those With Advanced Illnesses. J Palliat Care. 2020 May 28; 825859720928623 [Epub ahead of print]
    View PubMed
  9. Childs DS, Yoon HH, Eiring RA, Jin Z, Jochum JA, Pitot HC, Jatoi A. Falls: descriptive rates and circumstances in age-unspecified patients with locally advanced esophageal cancer. Support Care Cancer. 2020 May 24 [Epub ahead of print]
    View PubMed
  10. Duong Q, Mandrekar SJ, Winham SJ, Cook K, Jatoi A, Le-Rademacher JG. Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials. J Cancer Educ. 2020 May 8 Epub 2020 May 08
    View PubMed
  11. Cathcart-Rake E, O'Connor JM, Jacobson A, McGuire L, Jatoi A. How (and why) to ask the older cancer patient about sexual health and sexual minority status. J Geriatr Oncol. 2020 May; 11 (4):576-578 Epub 2019 Aug 22
    View PubMed
  12. Cathcart-Rake E, O'Connor J, Ridgeway JL, Breitkopf CR, Kaur JS, Mitchell J, Leventakos K, Jatoi A. Patients' Perspectives and Advice on How to Discuss Sexual Orientation, Gender Identity, and Sexual Health in Oncology Clinics. Am J Hosp Palliat Care. 2020 Mar 26; 1049909120910084 [Epub ahead of print]
    View PubMed
  13. Elias R, Loh KP, Targia V, Whitehead M, Canin B, Jatoi A, Loscalzo M, Mohile S. Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core. J Geriatr Oncol. 2020 Mar; 11 (2):347-349 Epub 2019 Aug 02
    View PubMed
  14. Smith C, Hendrickson AW, Grudem M, Klampe C, Deering E, Jatoi A. Loratadine for Paclitaxel-Induced Myalgias and Arthralgias. Am J Hosp Palliat Care. 2020 Mar; 37 (3):235-238 Epub 2019 July 17
    View PubMed
  15. Adjei A, Buckner JC, Cathcart-Rake E, Chen H, Cohen HJ, Dao D, De Luca JE, Feliciano J, Freedman RA, Goldberg RM, Hopkins J, Hubbard J, Jatoi A, Karuturi M, Kemeny M, Kimmick GG, Klepin HD, Krok-Schoen JL, Lafky JM, Le-Rademacher JG, Li D, Lichtman SM, Maggiore R, Mandelblatt J, Morrison VA, Muss HB, Ojelabi MO, Sedrak MS, Subbiah N, Sun V, Tuttle S, VanderWalde N, Wildes T, Wong ML, Woyach J, Alliance Cancer in the Older Adult Committee:. Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology. J Geriatr Oncol. 2020 Mar; 11 (2):179-183 Epub 2019 June 11
    View PubMed
  16. Karuturi MS, Sedrak MS, Magnuson A, Freedman R, Jatoi A, Smith BD, Kimmick GG. Breast cancer and aging: Standing on the shoulders of a giant. J Geriatr Oncol. 2020 Mar; 11 (2):212-216 Epub 2019 June 11
    View PubMed
  17. McCleary-Wheeler AL, Carr RM, Palmer SR, Smyrk TC, Allred JB, Almada LL, Tolosa EJ, Lamberti MJ, Marks DL, Borad MJ, Molina JR, Qi Y, Lingle WL, Grothey A, Pitot HC, Jatoi A, Northfelt DW, Bryce AH, McWilliams RR, Okuno SH, Haluska P, Kim GP, Colon-Otero G, Lowe VJ, Callstrom MR, Ma WW, Bekaii-Saab T, Hung MC, Erlichman C, Fernandez-Zapico ME. Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer. Pancreatology. 2020 Jan; 20 (1):101-109 Epub 2019 Nov 21
    View PubMed
  18. Dao D, O'Connor JM, Jatoi A, Ridgeway J, Deering E, Schwecke A, Breitkopf CR, Huston O, Le-Rademacher JG. A qualitative study of healthcare-related experiences of non-smoking women with lung cancer. Support Care Cancer. 2020 Jan; 28 (1):123-130 Epub 2019 Apr 15
    View PubMed
  19. Hendrix K, Wilson D, Kievman MJ, Jatoi A. Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups. Curr Oncol Rep. 2019 Dec 19; 21 (12):113
    View PubMed
  20. Le-Rademacher JG, Storrick EM, Jatoi A. Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss. J Cachexia Sarcopenia Muscle. 2019 Dec; 10 (6):1175-1182 Epub 2019 Aug 20
    View PubMed
  21. Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi A. Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26 (13):4213-4221 Epub 2019 Oct 11
    View PubMed
  22. Jatoi A, Laird BJA. Editorial: Merging therapeutics and supportive care: synergy and yield. Curr Opin Support Palliat Care 2019 Dec; 13 (4):277-278
    View PubMed
  23. Dunne RF, Loh KP, Williams GR, Jatoi A, Mustian KM, Mohile SG. Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review. Cancers (Basel). 2019 Nov 25; 11 (12)
    View PubMed
  24. Tilburt J, Yost KJ, Lenz HJ, Zuniga ML, O'Byrne T, Branda ME, Leppin AL, Kimball B, Fernandez C, Jatoi A, Barwise A, Kumbamu A, Montori V, Koenig BA, Geller G, Larson S, Roter DL. A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context. Oncologist. 2019 Nov; 24 (11):e1180-e1189 Epub 2019 May 17
    View PubMed
  25. Ustun C, Le-Rademacher J, Wang HL, Othus M, Sun Z, Major B, Zhang MJ, Storrick E, Lafky JM, Chow S, Mrozek K, Attar EC, Nand S, Bloomfield CD, Cripe LD, Tallman MS, Appelbaum F, Larson RA, Marcucci G, Roboz GJ, Uy GL, Stone RM, Jatoi A, Shea TC, de Lima M, Foran JM, Sandmaier BM, Litzow MR, Erba HP, Hurria A, Weisdorf DJ, Artz AS. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia. 2019 Nov; 33 (11):2599-2609 Epub 2019 May 09
    View PubMed
  26. Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD. Sarcopenia: A Time for Action. An SCWD Position Paper. J Cachexia Sarcopenia Muscle. 2019 Oct; 10 (5):956-961 Epub 2019 Sept 15
    View PubMed
  27. Muss HB, Polley MC, Berry DA, Liu H, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Kartcheske PA, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Sutton LM, Magrinat G, Parker BA, Hart RD, Grenier D, Hurria A, Jatoi A, Norton L, Hudis CA, Winer EP, Carey L. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 Sep 10; 37 (26):2338-2348 Epub 2019 July 24
    View PubMed
  28. Balko R, Hurley R, Jatoi A. Poly (ADP-Ribose) Polymerase Inhibition for Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Placebo-Controlled Trials. J Palliat Med. 2019 Aug; 22 (8):977-980 Epub 2019 Mar 06
    View PubMed
  29. Warsame R, Kennedy CC, Kumbamu A, Branda M, Fernandez C, Kimball B, Leppin AL, O'Byrne T, Jatoi A, Lenz HJ, Tilburt JC. Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study. J Oncol Pract. 2019 Jun 4; JOP1800618 Epub 2019 June 04
    View PubMed
  30. Le-Rademacher JG, Storrick EM, Jatoi A, Mandrekar SJ. Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun; 3 (2):176-182 Epub 2019 May 27
    View PubMed
  31. Cathcart-Rake EJ, Breitkopf CR, Kaur J, O'Connor J, Ridgeway JL, Jatoi A. Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health. Am J Hosp Palliat Care. 2019 Jun; 36 (6):533-537 Epub 2019 Jan 01
    View PubMed
  32. Le-Rademacher JG, Rowland K, Atherton PJ, Dakhil C, Sun Z, Tan A, Schmidt L, Nguyen PL, Radecki Breitkopf C, Pittelkow M, Tindall D, Menon S, Jatoi A. Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series. Am J Hosp Palliat Care. 2019 Jun; 36 (6):519-525 Epub 2019 Jan 02
    View PubMed
  33. Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). Oncologist. 2019 Jun; 24 (6):e284-e291 Epub 2019 Apr 11
    View PubMed
  34. Hurria A, Soto-Perez-de-Celis E, Allred JB, Cohen HJ, Arsenyan A, Ballman K, Le-Rademacher J, Jatoi A, Filo J, Mandelblatt J, Lafky JM, Kimmick G, Klepin HD, Freedman RA, Burstein H, Gralow J, Wolff AC, Magrinat G, Barginear M, Muss H. Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer. J Am Geriatr Soc. 2019 May; 67 (5):920-927 Epub 2018 Aug 26
    View PubMed
  35. Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi A. Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. Oncologist. 2019 May; 24 (5):617-623 Epub 2018 Nov 08
    View PubMed
  36. Dunne RF, Roussel B, Culakova E, Pandya C, Fleming FJ, Hensley B, Magnuson AM, Loh KP, Gilles M, Ramsdale E, Maggiore RJ, Jatoi A, Mustian KM, Dale W, Mohile SG. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol. 2019 May; 10 (3):415-419 Epub 2018 Sept 05
    View PubMed
  37. Cathcart-Rake EJ, Zemla T, Jatoi A, Weaver KE, Neuman H, Kazak AE, Carlos R, Gansauer L, Unger JM, Pajewski NM, Kamen C. Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Cancer. 2019 Apr 15; 125 (8):1313-1318 Epub 2018 Dec 18
    View PubMed
  38. Leventakos K, Schwecke AJ, Deering E, Cathcart-Rake E, Sanh AC, Jatoi A. The Need to Prioritize and Re-prioritize Palliative Care Options: Smoking Cessation as a Case-in-Point. Curr Treat Options Oncol. 2019 Mar 22; 20 (4):33
    View PubMed
  39. Dao D, O’Connor JM, Jatoi A, Ridgeway J, Deering E, Schwecke A, Radecki C, Huston O, Le-Rademacher JG. A Qualitative Study of Health Care-Related Experiences of Lung Cancer in Non-Smoking Women Supportive Care Cancer - accepted. 2019.
  40. Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP, Li M. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology. 2019 Feb; 156 (3):722-734.e6 Epub 2018 Oct 17
    View PubMed
  41. Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJS, Anker SD. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019 Feb; 10 (1):22-34
    View PubMed
  42. Balko RA, Hendrickson AW, Grudem ME, Klampe CM, Jatoi A. Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer? Am J Hosp Palliat Care. 2019 Jan; 36 (1):72-75 Epub 2018 July 08
    View PubMed
  43. Childs DS, Looker S, Le-Rademacher J, Ridgeway JL, Breitkopf CR, Jatoi A. What occurs in the other 20% of cancer patients with chemotherapy-induced nausea and vomiting (CINV)? A single-institution qualitative study. Support Care Cancer. 2019 Jan; 27 (1):249-255 Epub 2018 June 25
    View PubMed
  44. Childs DS, Jatoi A. A hunger for hunger: a review of palliative therapies for cancer-associated anorexia. Ann Palliat Med. 2019 Jan; 8 (1):50-58 Epub 2018 May 24
    View PubMed
  45. Berent TE, Dorschner JM, Meyer T, Craig TA, Wang X, Kunz H, Jatoi A, Lanza IR, Chen H, Kumar R. Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice. PLoS One. 2019; 14 (12):e0226440 Epub 2019 Dec 18
    View PubMed
  46. Laird BJA, Jatoi A. 'The shoulders, clavicles, chest and thighs melt away': a compilation of reviews on cachexia. Curr Opin Support Palliat Care 2018 Dec; 12 (4):393
    View PubMed
  47. Asiedu GB, Ridgeway JL, Carroll K, Jatoi A, Radecki Breitkopf C. "Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy. Health Expect. 2018 Dec; 21 (6):981-989 Epub 2018 Apr 14
    View PubMed
  48. Cathcart-Rake E, Smith D, Zahrieh D, Jatoi A, Yang P, Loprinzi CL. Nasal vestibulitis: an under-recognized and under-treated side effect of cancer treatment? Support Care Cancer. 2018 Nov; 26 (11):3909-3914 Epub 2018 May 24
    View PubMed
  49. Bartlett DJ, Childs DS, Breitkopf CR, Grudem ME, Mitchell JL, Looker SA, Ridgeway JL, Lee JL, Butterfield JH, Weroha SJ, Jatoi A. Chemotherapy Acute Infusion Reactions: A Qualitative Report of the Perspectives of Patients With Cancer. Am J Hosp Palliat Care. 2018 Nov; 35 (11):1384-1389 Epub 2018 May 03
    View PubMed
  50. Li D, McCall LM, Hahn OM, Hudis CA, Cohen HJ, Muss HB, Jatoi A, Lafky JM, Ballman KV, Winer EP, Tripathy D, Schneider B, Barry W, Dickler MN, Hurria A. Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study. Breast Cancer Res Treat. 2018 Sep; 171 (2):325-334 Epub 2018 May 22
    View PubMed
  51. Doles JD, Hogan KA, O'Connor J, Wahner Hendrickson AE, Huston O, Jatoi A. Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients. J Palliat Med. 2018 Sep; 21 (9):1334-1338 Epub 2018 May 24
    View PubMed
  52. Feliciano JL, Le-Rademacher JG, Gajra A, Edelman MJ, Zemla T, McMurray R, Chen H, Hurria A, Muss H, Cohen HJ, Lilenbaum R, Jatoi A. Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622). J Geriatr Oncol. 2018 Sep; 9 (5):501-506 Epub 2018 May 27
    View PubMed
  53. Freedman RA, Dockter TJ, Lafky JM, Hurria A, Muss HJ, Cohen HJ, Jatoi A, Kemeny MM, Ruddy KJ. Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602). Oncologist. 2018 Sep; 23 (9):1016-1023 Epub 2018 Apr 19
    View PubMed
  54. Tallarico M, Foster JC, Seisler D, Lafky JM, Hurria A, Jatoi A, Cohen HJ, Muss HB, Bartlett N, Cheson BD, Jung SH, Leonard JP, Byrd JC, Nabhan C. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611). J Geriatr Oncol. 2018 Jul; 9 (4):321-328 Epub 2018 Apr 17
    View PubMed
  55. Gajra A, Zemla TJ, Jatoi A, Feliciano JL, Wong ML, Chen H, Maggiore R, McMurray RP, Hurria A, Muss HB, Cohen HJ, Lafky J, Edelman MJ, Lilenbaum R, Le-Rademacher JG. Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711). J Thorac Oncol. 2018 Jul; 13 (7):996-1003 Epub 2018 Mar 30
    View PubMed
  56. Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF. The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention. JCSM Clin Rep. 2018 Jul-Dec; 3 (2)
    View PubMed
  57. Lacouture ME, Anadkat M, Jatoi A, Garawin T, Bohac C, Mitchell E. Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer. 2018 Jun; 17 (2):85-96 Epub 2017 Dec 13
    View PubMed
  58. Kimball BC, Geller G, Warsame R, Kumbamu A, Jatoi A, Koenig B, Tilburt JC. Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years. Oncologist. 2018 Jun; 23 (6):639-641 Epub 2018 Mar 09
    View PubMed
  59. Xie D, Allen MS, Marks R, Jiang G, Sun Z, Nichols F, Zhang M, Chen C, Aubry MC, Jatoi A, Garces YI, Mansfield A, Wigle D, Molina J, Deschamps C, Yang P. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers. Eur J Cardiothorac Surg. 2018 Jun 1; 53 (6):1214-1222
    View PubMed
  60. Morrison VA, McCall L, Muss HB, Jatoi A, Cohen HJ, Cirrincione CT, Ligibel JA, Lafky JM, Hurria A. The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436). J Geriatr Oncol. 2018 May; 9 (3):228-234 Epub 2017 Dec 08
    View PubMed
  61. Gajra A, McCall L, Muss HB, Cohen HJ, Jatoi A, Ballman KV, Partridge AH, Sutton L, Parker BA, Magrinat G, Klepin HD, Lafky JM, Hurria A. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 May; 9 (3):221-227 Epub 2018 Mar 28
    View PubMed
  62. Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer. J Oncol Pract. 2018 Apr; 14 (4):e211-e220 Epub 2018 Mar 20
    View PubMed
  63. Cathcart-Rake EJ, Lightner DJ, Quevedo FJ, Ertz DC, Jatoi A. Cancer in Transgender Patients: One Case in 385,820 Is Indicative of a Paucity of Data. J Oncol Pract. 2018 Apr; 14 (4):270-272 Epub 2017 Dec 19
    View PubMed
  64. Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R, Iyengar P. Prevalence and Survival Impact of Pretreatment Cancer-Associated Weight Loss: A Tool for Guiding Early Palliative Care. J Oncol Pract. 2018 Apr; 14 (4):e238-e250 Epub 2018 Feb 21
    View PubMed
  65. Yusuf N, Jatoi A. Cancer-associated weight loss: releasing its firm grip on negative clinical outcomes. Curr Opin Support Palliat Care 2017 Dec; 11 (4):259-260
    View PubMed
  66. Hopkins JO, Allred J, Hurria A, Jatoi A, Lafky JM, Cohen H, Hudis C, Winer E, Mandelblatt J, Partridge A, Carey L, Muss HB. Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302). Breast Cancer Res Treat. 2017 Dec; 166 (3):793-808 Epub 2017 Aug 20
    View PubMed
  67. Foster JC, Le-Rademacher JG, Feliciano JL, Gajra A, Seisler DK, DeMatteo R, Lafky JM, Hurria A, Muss HB, Cohen HJ, Jatoi A. Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort. Cancer. 2017 Nov 1; 123 (21):4193-4198 Epub 2017 July 12
    View PubMed
  68. Carr RM, Enriquez-Hesles E, Olson RL, Jatoi A, Doles J, Fernandez-Zapico ME. Epigenetics of cancer-associated muscle catabolism. Epigenomics 2017 Oct; 9 (10):1259-1265 Epub 2017 Sept 25
    View PubMed
  69. McWilliams RR, Foster NR, Mahoney MR, Smyrk TC, Murray JA, Ames MM, Horvath LE, Schneider DJ, Schneider DJ, Hobday TJ, Jatoi A, Meyers JP, Goetz MP. North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. Cancer. 2017 Sep 15; 123 (18):3494-3501 Epub 2017 May 10
    View PubMed
  70. Le-Rademacher JG, Crawford J, Evans WJ, Jatoi A. Overcoming obstacles in the design of cancer anorexia/weight loss trials. Crit Rev Oncol Hematol. 2017 Sep; 117:30-37 Epub 2017 June 24
    View PubMed
  71. Jatoi A, Steen PD, Atherton PJ, Moore DF, Rowland KM, Le-Lindqwister NA, Adonizio CS, Jaslowski AJ, Sloan J, Loprinzi C. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Ann Oncol. 2017 Aug 1; 28 (8):1957-1963
    View PubMed
  72. Shin JY, Kizilbash SH, Robinson S, Uhm JH, Jatoi A. Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma. Am J Hosp Palliat Care. 2017 Aug; 34 (7):650-653 Epub 2016 May 05
    View PubMed
  73. Colon-Otero G, Weroha SJ, Foster NR, Haluska P, Hou X, Wahner-Hendrickson AE, Jatoi A, Block MS, Dinh TA, Robertson MW, Copland JA. Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers. Gynecol Oncol. 2017 Jul; 146 (1):64-68 Epub 2017 Apr 28
    View PubMed
  74. Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA, Petersen GM. Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2017 Jun; 26 (6):971-974 Epub 2017 Mar 06
    View PubMed
  75. Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J. Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat. 2017 Jun; 163 (2):391-398 Epub 2017 Mar 10
    View PubMed
  76. Mehner C, Oberg AL, Goergen KM, Kalli KR, Maurer MJ, Nassar A, Goode EL, Keeney GL, Jatoi A, Radisky DC, Radisky ES. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. Genes Cancer. 2017 May; 8 (5-6):589-599
    View PubMed
  77. Kim DW, Garon EB, Jatoi A, Keefe DM, Lacouture ME, Sonis S, Gernhardt D, Wang T, Giri N, Doherty JP, Nadanaciva S, O'Connell J, Sbar E, Cho BC. Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042). Lung Cancer. 2017 Apr; 106:76-82 Epub 2017 Feb 01
    View PubMed
  78. Piderman KM, Radecki Breitkopf C, Jenkins SM, Lapid MI, Kwete GM, Sytsma TT, Lovejoy LA, Yoder TJ, Jatoi A. The impact of a spiritual legacy intervention in patients with brain cancers and other neurologic illnesses and their support persons. Psychooncology. 2017 Mar; 26 (3):346-353 Epub 2015 Dec 07
    View PubMed
  79. Jatoi A, Grudem ME, Dockter TJ, Block MS, Villasboas JC, Tan A, Deering E, Kasi PM, Mansfield AS, Botero JP, Okuno SH, Smith DR, Fields AP. A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome. Support Care Cancer. 2017 Mar; 25 (3):833-838 Epub 2016 Nov 12
    View PubMed
  80. Ridgeway JL, Asiedu GB, Carroll K, Tenney M, Jatoi A, Radecki Breitkopf C. Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study. Patient Educ Couns. 2017 Feb; 100 (2):349-354 Epub 2016 Aug 22
    View PubMed
  81. Freedman RA, Foster JC, Seisler DK, Lafky JM, Muss HB, Cohen HJ, Mandelblatt J, Winer EP, Hudis CA, Partridge AH, Carey LA, Cirrincione C, Moreno-Aspitia A, Kimmick G, Jatoi A, Hurria A. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. J Clin Oncol. 2017 Feb; 35 (4):421-431 Epub 2016 Dec 19
    View PubMed
  82. Piderman KM, Egginton JS, Ingram C, Dose AM, Yoder TJ, Lovejoy LA, Swanson SW, Hogg JT, Lapid MI, Jatoi A, Remtema MS, Tata BS, Breitkopf CR. I'm Still Me: Inspiration and Instruction from Individuals with Brain Cancer. J Health Care Chaplain. 2017 Jan-Mar; 23 (1):15-33 Epub 2016 July 11
    View PubMed
  83. Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 Jan; 161 (2):363-373 Epub 2016 Nov 19
    View PubMed
  84. Childs DS, Jacobson AC, Mitchell JL, Hubbard JM, Yoon HH, Finnes H, Grothey A, Jatoi A. Prescriber adherence to antiemetic guidelines with the new agent trifuridine-tipiracil Journal of Community and Supportive Oncology. 2017; 15: (3)e142-6.
  85. Egan JB, Marks DL, Hogenson TL, Vrabel AM, Sigafoos AN, Tolosa EJ, Carr RM, Safgren SL, Hesles EE, Almada LL, Romecin-Duran PA, Iguchi E, Ala'Aldeen A, Kocher JA, Oliver GR, Prodduturi N, Mead DW, Hossain A, Huneke NE, Tagtow CM, Ailawadhi S, Ansell SM, Banck MS, Bryce AH, Carballido EM, Chanan-Khan AA, Curtis KK, Resnik E, Gawryletz CD, Go RS, Halfdanarson TR, Ho TH, Joseph RW, Kapoor P, Mansfield AS, Meurice N, Nageswara Rao AA, Nowakowski GS, Pardanani A, Parikh SA, Cheville JC, Feldman AL, Ramanathan RK, Robinson SI, Tibes R, Finnes HD, McCormick JB, McWilliams RR, Jatoi A, Patnaik MM, Silva AC, Wieben ED, McAllister TM, Rumilla KM, Kerr SE, Lazaridis KN, Farrugia G, Stewart AK, Clark KJ, Kennedy EJ, Klee EW, Borad MJ, Fernandez-Zapico ME. Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma. JCO Precis Oncol. 2017; 2017 Epub 2017 Aug 01
    View PubMed
  86. Radecki Breitkopf C, Ridgeway JL, Asiedu GB, Carroll K, Tenney M, Jatoi A. Ovarian cancer patients' and their family members' perspectives on novel vaccine and virotherapy trials. Clin Trials. 2016 Dec; 13 (6):660-664 Epub 2016 June 27
    View PubMed
  87. Hofheinz RD, Deplanque G, Komatsu Y, Kobayashi Y, Ocvirk J, Racca P, Guenther S, Zhang J, Lacouture ME, Jatoi A. Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors. Oncologist. 2016 Dec; 21 (12):1483-1491 Epub 2016 July 22
    View PubMed
  88. Egloff H, Jatoi A. Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity? Cancer Invest. 2016 Nov 25; 34: (10)531-535.
    View PubMed
  89. Lerner L, Gyuris J, Nicoletti R, Gifford J, Krieger B, Jatoi A. Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss. Oncol Lett. 2016 Nov; 12 (5):4219-4223 Epub 2016 Sept 23
    View PubMed
  90. Ho TP, Foster NR, Jatoi A. A Single-Institution Study of Demographics and Outcomes of Adult Patients With Multiple Cancers. Cancer Control. 2016 Oct; 23: (4)455-460.
    View PubMed
  91. Kuhle CL, Kapoor E, Sood R, Thielen JM, Jatoi A, Faubion SS. Menopausal hormone therapy in cancer survivors: A narrative review of the literature. Maturitas. 2016 Oct; 92:86-96 Epub 2016 July 27
    View PubMed
  92. Jatoi A, Qin R, Satele D, Dakhil S, Kumar P, Johnson DB, Thomas SP, Stella PJ, Castillo J, Li M, Fernandez-Zapico M. "Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients. Support Care Cancer. 2016 Sep; 24 (9):3739-46 Epub 2016 Apr 02
    View PubMed
  93. Sood R, Novotny P, Faubion SS, Thielen JM, Shuster LT, Kuhle CL, Kapoor E, Marnach M, Barrette B, Jatoi A. Self-reported verbal abuse in 1300+ older women within a private, tertiary women's health clinic. Arch Gerontol Geriatr. 2016 Sep-Oct; 66:62-5 Epub 2016 May 12
    View PubMed
  94. Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer. Ann Oncol. 2016 Sep; 27 (9):1712-8 Epub 2016 June 10
    View PubMed
  95. Roter DL, Yost KJ, O'Byrne T, Branda M, Leppin A, Kimball B, Fernandez C, Jatoi A, Kumbamu A, Montori V, Koenig B, Geller G, Larson S, Tilburt J. Communication predictors and consequences of Complementary and Alternative Medicine (CAM) discussions in oncology visits. Patient Educ Couns. 2016 Sep; 99 (9):1519-25 Epub 2016 June 04
    View PubMed
  96. Kumar A, Moynagh MR, Multinu F, Cliby WA, McGree ME, Weaver AL, Young PM, Bakkum-Gamez JN, Langstraat CL, Dowdy SC, Jatoi A, Mariani A. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. Gynecol Oncol. 2016 Aug; 142 (2):311-6 Epub 2016 June 02
    View PubMed
  97. Harris FR, Kovtun IV, Smadbeck J, Multinu F, Jatoi A, Kosari F, Kalli KR, Murphy SJ, Halling GC, Johnson SH, Liu MC, Mariani A, Vasmatzis G. Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers. Sci Rep. 2016 Jul 20; 6:29831 Epub 2016 July 20
    View PubMed
  98. Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM. Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. J Geriatr Oncol. 2016 Jul; 7 (4):293-304 Epub 2016 May 31
    View PubMed
  99. Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W. Gaps in nutritional research among older adults with cancer. J Geriatr Oncol. 2016 Jul; 7 (4):281-92 Epub 2016 July 05
    View PubMed
  100. Shin JY, Kizilbash SH, Robinson SI, Uhm JH, Hammack JE, Lachance DH, Buckner JC, Jatoi A. Seizures in patients with primary brain tumors: what is their psychosocial impact? J Neurooncol. 2016 Jun; 128 (2):285-91 Epub 2016 Mar 15
    View PubMed
  101. Vegunta S, Kuhle C, Kling JM, Files JA, Kapoor E, David PS, Rullo J, Sood R, Thielen JM, Jatoi A, Schroeder DR, Faubion SS. The association between recent abuse and menopausal symptom bother: results from the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS). Menopause. 2016 May; 23 (5):494-8
    View PubMed
  102. Kumar A, Mynderse L, Patel K, Grudem M, Bakkum-Gamez J, Longenbach S, Block MS, Pitot HC, Garovic V, Weroha SJ, Jatoi A. Ureteral obstruction in cancer patients: a qualitative study. Psychooncology. 2016 May; 25 (5):605-9 Epub 2015 June 22
    View PubMed
  103. Tran E, Spiceland C, Sandhu NP, Jatoi A. Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer. Am J Hosp Palliat Care. 2016 Apr; 33 (3):272-5 Epub 2014 Dec 31
    View PubMed
  104. Jatoi A, Muss H, Allred JB, Cohen HJ, Ballman K, Hopkins JO, Gajra A, Lafky J, Wolff A, Kottschade L, Gralow J, Hurria A. Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301). Psychooncology. 2016 Apr; 25 (4):441-6 Epub 2015 May 20
    View PubMed
  105. Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff AC, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907. J Clin Oncol. 2016 Mar 1; 34 (7):699-705 Epub 2016 Jan 11
    View PubMed
  106. Jatoi A, Vierkant RA, Hawthorne KM, Block MS, Ramus SJ, Larson NB, Fridley BL, Goode EL. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology. 2016; 90 (2):59-68 Epub 2016 Jan 19
    View PubMed
  107. Fearon K, Argiles JM, Baracos VE, Bernabei R, Coats A, Crawford J, Deutz NE, Doehner W, Evans WJ, Ferrucci L, Garcia JM, Gralla RJ, Jatoi A, Kalantar-Zadeh K, Lainscak M, Morley JE, Muscaritoli M, Polkey MI, Rosano G, Rossi-Fanelli F, Schols AM, Strasser F, Vellas B, von Haehling S, Anker SD. Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle. 2015 Dec; 6 (4):272-4 Epub 2015 Nov 11
    View PubMed
  108. Mehner C, Oberg AL, Kalli KR, Nassar A, Hockla A, Pendlebury D, Cichon MA, Goergen KM, Maurer MJ, Goode EL, Keeney GL, Jatoi A, Sahin-Toth M, Copland JA, Radisky DC, Radisky ES. Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers. Oncotarget. 2015 Nov 3; 6 (34):35737-54
    View PubMed
  109. Jatoi A, Foster NR, Kalli KR, Vierkant RA, Zhang Z, Larson MC, Fridley B, Goode EL. Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival. BMC Cancer. 2015 Oct 15; 15:711.
    View PubMed
  110. Menon S, Foster NR, Looker S, Sorgatz K, Kasi PM, McWilliams RR, Jatoi A. Should Vital Signs Be Routinely Obtained Prior to Intravenous Chemotherapy? Results From a 2-Center Study. Cancer Control. 2015 Oct; 22 (4):515-9
    View PubMed
  111. Sadak KT, Bahr TL, Moen C, Neglia JP, Jatoi A. The clinical and research infrastructure of a childhood cancer survivor program. J Cancer Educ. 2015 Sep; 30(3):471-6.
    View PubMed
  112. Xie D, Marks R, Zhang M, Jiang G, Jatoi A, Garces YI, Mansfield A, Molina J, Yang P. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers. J Thorac Oncol. 2015 Aug; 10: (8)1213-20.
    View PubMed
  113. Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. J Palliat Med. 2015 Aug; 18: (8)707-10.
    View PubMed
  114. AlHilli MM, Bakkum-Gamez JN, Mariani A, Weaver AL, McGree ME, Keeney GL, Jatoi A, Dowdy SC, Podratz KC. Risk-adjusted outcomes in elderly endometrial cancer patients: implications of the contrasting impact of age on progression-free and cause-specific survival. Gynecol Oncol. 2015 Jul; 138(1):133-40. Epub 2015 Apr 17.
    View PubMed
  115. Piderman KM, Breitkopf CR, Jenkins SM, Lovejoy LA, Dulohery YM, Marek DV, Durland HL, Head DL, Swanson SW, Hogg JT, Evans JL, Jorgenson SE, Bunkowski LJ, Jones KL, Euerle TT, Kwete GM, Miller KA, Morris JR, Yoder TJ, Lapid MI, Jatoi A. The feasibility and educational value of Hear My Voice, a chaplain-led spiritual life review process for patients with brain cancers and progressive neurologic conditions. J Cancer Educ. 2015 Jun; 30 (2):209-12
    View PubMed
  116. Hubbard JM, Jatoi A. Incorporating biomarkers of frailty and senescence in cancer therapeutic trials. J Gerontol A Biol Sci Med Sci. 2015 Jun; 70(6):722-8. Epub 2014 Apr 26.
    View PubMed
  117. Patel K, Foster NR, Kumar A, Grudem M, Longenbach S, Bakkum-Gamez J, Haddock M, Dowdy S, Jatoi A. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015 May; 23 (5):1303-9 Epub 2014 Oct 23
    View PubMed
  118. Del Fabbro E, Jatoi A, Davis M, Fearon K, di Tomasso J, Vigano A. Health professionals' attitudes toward the detection and management of cancer-related anorexia-cachexia syndrome, and a proposal for standardized assessment. J Community Support Oncol. 2015 May; 13(5):181-7.
    View PubMed
  119. Piderman KM, Breitkopf CR, Jenkins SM, Euerle TT, Lovejoy LA, Kwete GM, Jatoi A. A Chaplain-led Spiritual Life Review Pilot Study for Patients with Brain Cancers and Other Degenerative Neurologic Diseases. Rambam Maimonides Med J. 2015 Apr; 6 (2):e0015 Epub 2015 Apr 29
    View PubMed
  120. Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J, Cen P, Xu J, Liu C, Long J, Guha S, Fu D, Ni Q, Jatoi A, Chari S, McCleary-Wheeler AL, Fernandez-Zapico ME, Li M, Yu X. A preoperative serum signature of CEA+/CA125+/ CA19-9=1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. Int J Cancer. 2015; 136(9):2216-27.
    View PubMed
  121. Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, Price W, Stewart M, Teknos TN, Moskowitz B. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer. 2015; 67(2):339-53.
    View PubMed
  122. Shinde S, Wanger T, Novotny P, Grudem M, Jatoi A. Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series. Eur J Gynaecol Oncol. 2015; 36(2):155-60.
    View PubMed
  123. Jatoi A, Radecki Breitkopf C, Foster NR, Block MS, Grudem M, Wahner Hendrickson A, Carlson RE, Barrette B, Karlin N, Fields AP. A mixed-methods feasibility trial of protein kinase C iota inhibition with auranofin in asymptomatic ovarian cancer patients. Oncology. 2015; 88 (4):208-13 Epub 2014 Dec 06
    View PubMed
  124. Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jacquelin-Ravel N, Jatoi A, Kaasa S, Strasser F, ESMO (European School of Medical Oncology). Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014 Aug; 25 (8):1492-9 Epub 2014 Feb 25
    View PubMed
  125. Gajra A, Jatoi A. Non-Small-Cell Lung Cancer in Elderly Patients: A Discussion of Treatment Options. J Clin Oncol. 2014 Jul 28. [Epub ahead of print]
    View PubMed
  126. Wanger T, Foster NR, Nguyen PL, Jatoi A. Patients' rationale for declining participation in a cancer-associated weight loss study. J Cachexia Sarcopenia Muscle. 2014 Jun; 5 (2):121-5 Epub 2014 Mar 13
    View PubMed
  127. Breitkopf CR, Stephens EK, Jatoi A. Hospice in end-of-life patients with cancer: does it lead to changes in nonhospice health care utilization after stopping cancer treatment? Am J Hosp Palliat Care. 2014 Jun; 31 (4):392-5 Epub 2013 May 10
    View PubMed
  128. Kenderian S, Stephens EK, Jatoi A. Ostomies in rectal cancer patients: what is their psychosocial impact? Eur J Cancer Care (Engl). 2014 May; 23 (3):328-32 Epub 2013 Oct 10
    View PubMed
  129. Egloff H, Jatoi A. Pemetrexed for ovarian cancer: a systematic review of the published literature and a consecutive series of patients treated in a nonclinical trial setting. Case Rep Oncol. 2014 May; 7 (2):541-9 Epub 2014 July 30
    View PubMed
  130. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy. Gynecol Oncol. 2014 Mar; 132 (3):578-84 Epub 2014 Jan 14
    View PubMed
  131. Jackson AE, Stephens EK, Jatoi A. Causes and palliation of transfusion-associated vaginal bleeding in patients with metastatic cancer. Int J Gynecol Cancer. 2014 Jan; 24 (1):172-5
    View PubMed
  132. Patel K, Stephens EK, Miller RC, Jatoi A. Incidence and outcomes of chemotherapy and radiation in morbidly obese patients with locally advanced lung and esophageal cancers: a single-institution experience. Cancer Control. 2014 Jan; 21 (1):63-6
    View PubMed
  133. Hayman SR, Calle JC, Jatoi A, Craici IM, Wagner SJ, Weaver AL, Greene EL, Grande JP, Garovic VD. Urinary podocyte excretion and proteinuria in patients treated with antivascular endothelial growth factor therapy for solid tumor malignancies. Oncology. 2014; 86(5-6):271-8. Epub 2014 Jun 04.
    View PubMed
  134. Menon SP, Jatoi A. Non-small-cell lung cancer in the elderly with an emphasis on chemotherapy in the adjuvant and metastatic disease settings Lung Cancer Management. 2014; 3 (5):411-6
  135. Patel K, Foster NR, Farrell A, Le-Lindqwister NA, Mathew J, Costello B, Reynolds J, Meyers JP, Jatoi A. Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature. J Cancer Educ. 2013 Dec; 28 (4):770-6
    View PubMed
  136. Mansfield AS, Fields AP, Jatoi A, Qi Y, Adjei AA, Erlichman C, Molina JR. Phase I dose escalation study of the PKCiota inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Anticancer Drugs. 2013 Nov; 24 (10):1079-83
    View PubMed
  137. Kimball BC, James KM, Yost KJ, Fernandez CA, Kumbamu A, Leppin AL, Robinson ME, Geller G, Roter DL, Larson SM, Lenz HJ, Garcia AA, Braddock Iii CH, Jatoi A, de Nuncio ML, Montori VM, Koenig BA, Tilburt JC. Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology. BMC Cancer. 2013 Oct 04; 13(1):455.
    View PubMed
  138. Lim MY, Stephens EK, Novotny P, Price K, Salayi M, Roeker L, Peethambaram P, Jatoi A. Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival. J Geriatr Oncol. 2013 Jul; 4(3):249-54.
    View PubMed
  139. Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Nutritional status, CT body composition measures and survival in ovarian cancer. Gynecol Oncol. 2013 Jun; 129(3):548-53. Epub 2013 Mar 21.
    View PubMed
  140. Griffin BR, Stephens EK, Jatoi A. Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed? Observations from a Case Series. Case Rep Oncol. 2013 May; 6 (2):339-42 Epub 2013 June 26
    View PubMed
  141. Mansfield AS, Jatoi A. Asphyxiation with a fentanyl patch. Case Rep Oncol. 2013 May; 6 (2):242-4 Epub 2013 May 01
    View PubMed
  142. Feely MA, Collins CS, Daniels PR, Kebede EB, Jatoi A, Mauck KF. Preoperative testing before noncardiac surgery: guidelines and recommendations. Am Fam Physician. 2013 Mar 15; 87(6):414-8.
    View PubMed
  143. Stauder MC, Romero Y, Kabat B, Atherton PJ, Geno D, Deschamps C, Jatoi A, Sloan JA, Botros M, Jung KW, Arora AS, Miller RC, EABE Registry Consortium. Overall survival and self-reported fatigue in patients with esophageal cancer. Support Care Cancer. 2013 Feb; 21 (2):511-9 Epub 2012 July 29
    View PubMed
  144. Garcia JM, Jatoi A, Del Fabbro E. The potential of ghrelin in cancer anorexia-cachexia. European Oncology and Haematology. 2013; 9(2):77-83.
  145. Jatoi A, Allred JB, Suman VJ, Creagan ET, Croghan GA, Amatruda T, Markovic SN. Is Age >/= 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials. J Geriatr Oncol. 2012 Oct 1; 3 (4):307-311 Epub 2012 May 07
    View PubMed
  146. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20 (8):1729-35 Epub 2011 Sept 16
    View PubMed
  147. Ramiscal JA, Jatoi A. Nasal septal perforation from bevacizumab: a discussion of outcomes, management, and pharmacovigilance. Curr Oncol Rep. 2012 Aug; 14 (4):307-10
    View PubMed
  148. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer. 2012 Jul; 48(11):1593-601. Epub 2012 Jan 12.
    View PubMed
  149. Poterucha T, Burnette B, Jatoi A. A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol. 2012 Jun; 29 (2):1005-9 Epub 2011 Mar 12
    View PubMed
  150. Jatoi A. Adjuvant chemotherapy and targeted therapy in elderly non-small-cell lung cancer patients. Aging health. 2012 Jun 1; 8 (3):309-316
    View PubMed
  151. Varkey P, Jatoi A, Williams A, Mayer A, Ko M, Files J, Blair J, Hayes S. The positive impact of a facilitated peer mentoring program on academic skills of women faculty. BMC Med Educ. 2012 Mar 23; 12:14
    View PubMed
  152. Breitkopf CR, Egginton JS, Naessens JM, Montori VM, Jatoi A. Who is counseled to lose weight? Survey results and anthropometric data from 3,149 lower socioeconomic women. J Community Health. 2012 Feb; 37 (1):202-7
    View PubMed
  153. Yang P, Cheville AL, Wampfler JA, Garces YI, Jatoi A, Clark MM, Cassivi SD, Midthun DE, Marks RS, Aubry MC, Okuno SH, Williams BA, Nichols FC, Trastek VF, Sugimura H, Sarna L, Allen MS, Deschamps C, Sloan JA. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012 Jan; 7 (1):64-70
    View PubMed
  154. Yang P, Kulig K, Boland JM, Erickson-Johnson MR, Oliveira AM, Wampfler J, Jatoi A, Deschamps C, Marks R, Fortner C, Stoddard S, Nichols F, Molina J, Aubry MC, Tang H, Yi ES. Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma. J Thorac Oncol. 2012 Jan; 7 (1):90-7
    View PubMed
  155. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82 (6):315-20 Epub 2012 May 10
    View PubMed
  156. Stephens EK, Nguyen PL, Radecki Breitkopf C, Jatoi A. Former military officers from the Republic of Vietnam now living in the united states (US): exploring their perceptions of the US healthcare system. J Community Health. 2011 Dec; 36 (6):992-8
    View PubMed
  157. Jatoi A, Qi Y, Wampfler JA, Busta AJ, Yang P, Mandrekar S. The purported effects of alcohol on appetite and weight in lung cancer patients. Nutr Cancer. 2011 Nov; 63: (8)1251-5.
    View PubMed
  158. Coleman S, Kovtun I, Nguyen PL, Pittelkow M, Jatoi A. A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors. Psychooncology. 2011 Nov; 20 (11):1246-9 Epub 2010 Sept 23
    View PubMed
  159. Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross HM, Loprinzi CL, North Central Cancer Treatment Group. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Support Care Cancer. 2011 Oct; 19 (10):1601-7 Epub 2010 Sept 06
    View PubMed
  160. Coleman S, Peethambaram PP, Jatoi A. Consumer beware: a systematic assessment of potential bias in the lay electronic media to examine the portrayal of "PARP" inhibitors for cancer treatment. J Cancer Educ. 2011 Sep; 26 (3):474-7
    View PubMed
  161. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manage. 2011 Aug; 42 (2):213-21 Epub 2011 Mar 12
    View PubMed
  162. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, Jatoi A, Yang P. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manage. 2011 Aug; 42 (2):202-12 Epub 2011 Mar 12
    View PubMed
  163. Kovtun IV, Harris KJ, Jatoi A, Jevremovic D. Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice. Carcinogenesis. 2011 Jul; 32 (7):1085-92 Epub 2011 May 05
    View PubMed
  164. Jatoi A, Breitkopf CR. Is Spanish language a barrier to domestic violence assessment? J Womens Health (Larchmt). 2011 Jul; 20 (7):1111-6 Epub 2011 June 01
    View PubMed
  165. Stephens EK, Nguyen PL, Jatoi A. Practical strategies to circumvent and/or surmount six barriers in health disparities research: observations from a pilot project among Vietnamese Americans. J Cancer Educ. 2011 Jun; 26 (2):243-7
    View PubMed
  166. Mitchell J, Jatoi A. Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider. Semin Oncol. 2011 Jun; 38 (3):439-42
    View PubMed
  167. Mc Kean H, Stella PJ, Hillman SL, Rowland KM, Cannon MW, Behrens RJ, Gross GG, Sborov MD, Friedman EL, Jatoi A. Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222. Cancer Invest. 2011 May; 29 (4):266-71 Epub 2011 Feb 23
    View PubMed
  168. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May; 12(5):489-95. Epub 2011 Feb 04.
    View PubMed
  169. Ramiscal JA, Jatoi A. Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients. Acta Oncol. 2011 May; 50 (4):578-81 Epub 2010 Nov 26
    View PubMed
  170. Sood R, Shuster L, Smith R, Vincent A, Jatoi A. Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med. 2011 Mar-Apr; 24 (2):202-10
    View PubMed
  171. Solomon BM, Jatoi A. Epidermal growth factor receptor (EGFR) inhibitor-induced rash: a consecutive patient series that illustrates the need for rigorous palliative trials. J Palliat Med. 2011 Feb; 14 (2):153-6 Epub 2011 Jan 12
    View PubMed
  172. Vaidya R, Sood R, Karlin N, Jatoi A. Benzodiazepine use in breast cancer survivors: findings from a consecutive series of 1,000 patients. Oncology. 2011; 81 (1):9-11 Epub 2011 Sept 02
    View PubMed
  173. Vincent A, Whipple MO, Luedtke CA, Oh TH, Sood R, Smith RL, Jatoi A. Pain and other symptom severity in women with fibromyalgia and a previous hysterectomy. J Pain Res. 2011; 4:325-9 Epub 2011 Oct 07
    View PubMed
  174. Tan TS, Jatoi A. End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference? Oncology. 2011; 80 (1-2):118-22 Epub 2011 June 14
    View PubMed
  175. Sood R, Jatoi A. Integrative nutritional approaches to loss of weight and appetite in patients with advanced cancer. European Journal of Integrative Medicine. 2011; 3(3):e233-6.
  176. Jatoi A. Integrative and complementary medicine among cancer patients: At what price? European Journal of Integrative Medicine. 2011; 3(3):e139-41.
  177. Mateen FJ, Nassar A, Bardia A, Jatoi A, Haddock MG, Buckner JC, Lachance DH. Spinal intradural extraosseous Ewing's sarcoma. Rare Tumors. 2011; 3(1):e7. Epub 2011 Mar 30.
    View PubMed
  178. Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med. 2011; 62:265-79.
    View PubMed
  179. Aldairy Y, Nguyen PL, Jatoi A. Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting? Eur J Cancer Care (Engl). 2011 Jan; 20 (1):72-6
    View PubMed
  180. Butts M, Jatoi A. A systematic compilation of reports published on opioid-related problems. J Opioid Manag. 2011 Jan-Feb; 7 (1):35-45
    View PubMed
  181. Burnette B, Jatoi A. Parenteral nutrition in patients with cancer: recent guidelines and a need for further study. Curr Opin Support Palliat Care. 2010 Dec; 4(4):272-5.
    View PubMed
  182. Jatoi A, Soori G, Foster NR, Hiatt BK, Knost JA, Fitch TR, Callister MD, Nichols FC 3rd, Husted TM, Alberts SR. Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors. J Thorac Oncol. 2010 Dec; 5 (12):1994-8
    View PubMed
  183. Miller RC, Atherton PJ, Kabat BF, Fredericksen MB, Geno DM, Deschamps C, Jatoi A, Sloan JA, Romero Y. Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study. Dig Dis Sci. 2010 Oct; 55 (10):2860-8 Epub 2010 Jan 22
    View PubMed
  184. Jatoi A, Qi Y, Kendall G, Jiang R, McNallan S, Cunningham J, Mandrekar S, Yang P. The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer. 2010 Oct; 18 (10):1299-304 Epub 2009 Dec 15
    View PubMed
  185. Jatoi A, Schild SE, Foster N, Henning GT, Dornfeld KJ, Flynn PJ, Fitch TR, Dakhil SR, Rowland KM, Stella PJ, Soori GS, Adjei AA. A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422). Ann Oncol. 2010 Oct; 21 (10):2040-4 Epub 2010 June 21
    View PubMed
  186. Larson BR, Looker S, Herrera DM, Creagan ET, Hayman SR, Kaur JS, Jatoi A. Cancer patients and their companion animals: results from a 309-patient survey on pet-related concerns and anxieties during chemotherapy. J Cancer Educ. 2010 Sep; 25 (3):396-400 Epub 2010 Feb 24
    View PubMed
  187. Behl D, Jatoi A. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey. J Palliat Med. 2010 Jul; 13 (7):831-5
    View PubMed
  188. Jatoi A, Smith EL, Gunderson HD, Hartgers ML, Looker SA, Santana-Davila R, McWilliams RR. Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy. J Oncol Pract. 2010 Jul; 6 (4):210-2 Epub 2010 June 22
    View PubMed
  189. Halfdanarson TR, Jatoi A. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep. 2010 Jul; 12(4):247-52.
    View PubMed
  190. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer. 2010 May; 68 (2):234-9 Epub 2009 Aug 08
    View PubMed
  191. Jatoi A. Cancer chemotherapy: with or without food? Support Care Cancer. 2010 May; 18 Suppl 2:S13-6 Epub 2009 June 01
    View PubMed
  192. Jatoi A, Foster NR, Egner JR, Burch PA, Stella PJ, Rubin J, Dakhil SR, Sargent DJ, Murphy BR, Alberts SR. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol. 2010 Mar; 36 (3):601-6
    View PubMed
  193. Hartgers M, Jatoi A. E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication. J Palliat Med. 2010 Mar; 13 (3):335-7
    View PubMed
  194. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, Marks RS, Liu Y, Yang P. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010 Feb; 67(2):221-6. Epub 2009 Jun 03.
    View PubMed
  195. Wood LS, Lemont H, Jatoi A, Lacouture ME, Robert C, Keating K, Anderson R. Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors. Community Oncol. 2010; 7(1):23-9.
  196. Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA, Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Oncologist. 2010; 15 (9):1016-22 Epub 2010 Aug 26
    View PubMed
  197. Jatoi A, Hillman SL, Ziegler KL, Stella PJ, Soori GS, Rowland KM. Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222. Cancer Manag Res. 2009 Jun 17; 1:61-8 Epub 2009 June 17
    View PubMed
  198. Huang J, Jatoi A. Morbidity and mortality in patients with cancer who become nonambulatory after spinal cord compression: a case series on end-of-life care. J Palliat Med. 2009 Mar; 12 (3):219-22
    View PubMed
  199. Anderson R, Jatoi A, Robert C, Wood LS, Keating KN, Lacouture ME. Search for evidence-based approaches for the prevention and palliation of hand-foot skin reaction (HFSR) caused by the multikinase inhibitors (MKIs). Oncologist. 2009 Mar; 14(3):291-302. Epub 2009 Mar 10.
    View PubMed
  200. Donahue JM, Nichols FC, Li Z, Schomas DA, Allen MS, Cassivi SD, Jatoi A, Miller RC, Wigle DA, Shen KR, Deschamps C. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009 Feb; 87 (2):392-8; discussion 398-9
    View PubMed
  201. Jatoi A, Green EM, Rowland KM Jr, Sargent DJ, Alberts SR. Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147. Oncology. 2009; 77 (2):120-3 Epub 2009 July 22
    View PubMed
  202. Tan TS, Walia T, Galanis E, Goetz MP, Rubin J, Jatoi A. If you hold it off-hours, will they come? Results from a feasibility project intended to stimulate interest in the physician-investigator career path among medical oncology trainees. J Cancer Educ. 2009; 24 (3):200-3
    View PubMed
  203. Jacobs NL, Que FG, Miller RC, Vege SS, Farnell MB, Jatoi A. Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer. J Gastrointest Cancer. 2009; 40 (1-2):46-50
    View PubMed
  204. Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A. Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008 Dec; 4(6):1363-6.
    View PubMed
  205. Jatoi A, Nguyen PL. Side effects and pharmaceutical company bias: adverse event reporting in cancer supportive and palliative care trials. Expert Opin Investig Drugs. 2008 Dec; 17 (12):1787-90
    View PubMed
  206. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD. Cachexia: a new definition. Clin Nutr. 2008 Dec; 27(6):793-9. Epub 2008 Aug 21
    View PubMed
  207. Jatoi A, Nguyen PL. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Oncologist. 2008 Nov; 13 (11):1201-4 Epub 2008 Nov 06
    View PubMed
  208. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer. 2008 Aug 15; 113 (4):847-53
    View PubMed
  209. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ, Gunderson LL. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 2008 Jul 20; 26(21):3511-6.
    View PubMed
  210. Solomon BM, Jatoi A. Rash from EGFR inhibitors: opportunities and challenges for palliation. Curr Oncol Rep. 2008 Jul; 10 (4):304-8
    View PubMed
  211. Clark MM, Novotny PJ, Patten CA, Rausch SM, Garces YI, Jatoi A, Sloan JA, Yang P. Motivational readiness for physical activity and quality of life in long-term lung cancer survivors. Lung Cancer. 2008 Jul; 61 (1):117-22 Epub 2008 Feb 19
    View PubMed
  212. Mateen FJ, Jatoi A, Lineberry TW, Aranguren D, Creagan ET, Croghan GA, Jett JR, Marks RS, Molina JR, Richardson RL. Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psychooncology. 2008 Jul; 17 (7):721-5
    View PubMed
  213. Galanis E, Carlson SK, Foster NR, Lowe V, Quevedo F, McWilliams RR, Grothey A, Jatoi A, Alberts SR, Rubin J. Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer. Mol Ther. 2008 May; 16 (5):979-84 Epub 2008 Mar 18
    View PubMed
  214. McKean H, Looker S, Hartmann LC, Hayman SR, Kaur JS, McWilliams RR, Peethambaram PP, Stahl JF, Jatoi A. Are cancer survivors/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions. J Nutr Educ Behav. 2008 May-Jun; 40: (3)144-8.
    View PubMed
  215. Jatoi A, Dakhil SR, Foster NR, Ma C, Rowland KM Jr, Moore DF Jr, Jaslowski AJ, Thomas SP, Hauge MD, Flynn PJ, Stella PJ, Alberts SR. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). J Thorac Oncol. 2008 May; 3 (5):516-20
    View PubMed
  216. Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol. 2008 May-Jun; 6(5):234-7.
    View PubMed
  217. Jatoi A. Weight loss in patients with advanced cancer: effects, causes, and potential management. Curr Opin Support Palliat Care. 2008 Mar; 2(1):45-8.
    View PubMed
  218. Singh PP, Jatoi A. Do gender-based disparities in authorship also exist in cancer palliative care? A 15-year survey of the cancer palliative care literature. J Cancer Educ. 2008; 23(3):192-4.
    View PubMed
  219. Kovtun IV, Engh J, Jatoi A. A survey of patient advocates within the National Cancer Institute's Prostate Cancer SPORE Program: who are they? what motivates them? what might they tell us? J Cancer Educ. 2008; 23 (4):222-5
    View PubMed
  220. Tan TS, Jatoi A. An update on advance directives in the medical record: findings from 1186 consecutive patients with unresectable exocrine pancreas cancer. J Gastrointest Cancer. 2008; 39 (1-4):100-3 Epub 2009 Jan 06
    View PubMed
  221. Katipamula R, Jatoi A, Foster NR, Nichols F, Rubin J, Callister M, Gunderson L, Alberts S. Pemetrexed, Carboplatin, and Concomitant Radiation followed by Surgery for Locally Advanced Esophageal Cancer: Results of a Planned Interim Toxicity Analysis of North Central Cancer Treatment Group Study N044E. Clin Med Oncol. 2008; 2:223-5 Epub 2008 Apr 01
    View PubMed
  222. Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P. Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort. Oncologist. 2007 Dec; 12(12):1456-63.
    View PubMed
  223. Jatoi A, Martenson JA, Foster NR, McLeod HL, Lair BS, Nichols F, Tschetter LK, Moore DF Jr, Fitch TR, Alberts SR, North Central Cancer Treatment Group (N0044). Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044). Am J Clin Oncol. 2007 Oct; 30(5):507-13.
    View PubMed
  224. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007 Sep 15; 110(6):1396-403.
    View PubMed
  225. Alsawaf MA, Jatoi A. Shopping for nutrition-based complementary and alternative medicine on the Internet: how much money might cancer patients be spending online? J Cancer Educ. 2007 Fall; 22(3):174-6.
    View PubMed
  226. Schild SE, Mandrekar SJ, Jatoi A, McGinnis WL, Stella PJ, Deming RL, Jett JR, Garces YI, Allen KL, Adjei AA, North Central Cancer Treatment GroupThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic. The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer. Cancer. 2007 Jul 15; 110(2):363-8.
    View PubMed
  227. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007 Jun; 82(6):751-70.
    View PubMed
  228. Behl D, Jatoi A. Pharmacological options for advanced cancer patients with loss of appetite and weight. Expert Opin Pharmacother. 2007 Jun; 8 (8):1085-90
    View PubMed
  229. Ma C, Jatoi A. Wine for appetite loss: "how do you know?". J Clin Oncol. 2007 Apr 1; 25(10):1285-7.
    View PubMed
  230. Halyard MY, Jatoi A, Sloan JA, Bearden JD, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22.
    View PubMed
  231. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  232. Ma C, Mandrekar SJ, Alberts SR, Croghan GA, Jatoi A, Reid JM, Hanson LJ, Bruzek L, Tan AD, Pitot HC, Erlichman C, Wright JJ, Adjei AA. A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies. Cancer Chemother Pharmacol. 2007 Feb; 59(2):207-15. Epub 2006 Jun 9
    View PubMed
  233. Jatoi A, Burch P, Hillman D, Vanyo JM, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn PJ, Young C, Tan W, North Central Cancer Treatment Group. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group. Urology. 2007 Feb; 69 (2):289-94
    View PubMed
  234. Jatoi A. Sunshine and rash: Testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash. Supportive Cancer Ther. 2007; 4(4):198-202.
  235. Jatoi A, Nguyen PL, Foster N, Sun D, Stella PJ, Campbell M, Tschetter LK, Dakhil SR, Mailliard JA, Nikcevich DA. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol. 2007 Jan; 5(1):41-6.
    View PubMed
  236. McKean H, Miller RC, Jatoi A. Non-traumatic vertebral fractures in patients with locally advanced esophageal cancer: a previously unreported, unrecognized problem. Dis Esophagus. 2007; 20: (2)102-6.
    View PubMed
  237. Jatoi A, Aranguren D. A critical look at the role of chemotherapy in older patients with non-small cell lung cancer. J Thorac Oncol. 2007 Jan; 2(1):83-90.
    View PubMed
  238. Jatoi A, Dakhil S, Foster N, Ma C, Rowland K, Moore D, Jaslowksi A, Thomas S, Hauge M, Flynn P, Stella P, Alberts S. Bortezobim, Paclitaxel, and Carboplatin as a First-Line Regimen for Patients With Metastatic Esophageal Cancer: Phase II Results from the NCCTG (N044B). J Thorac Oncol. 2007; 3(5):516-20.
  239. Halfdanarson TR, Jatoi A. Chocolate as a cough suppressant: rationale and justification for an upcoming clinical trial. Support Cancer Ther. 2007 Jan 1; 4(2):119-22.
    View PubMed
  240. Jatoi A. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach. J Support Oncol. 2006 Nov-Dec; 4(10):499-502.
    View PubMed
  241. Jatoi A, Burch P, Hillman D, Vanyo J, Dakhil S, Nikcevich D, Rowland K, Morton R, Flynn P, Young C, Tan W. A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a phase II study from the North Central Cancer Treatment Group. J Urol. 2006 Oct 19; 69(2):289-294.
  242. Jatoi A, Jacobs JA, Zimmermann E, Johnson ME, Nguyen PL, Hartmann LC. Helping people cope with bereavement: an opportunity for health care providers to link Web-based resources across Minnesota. Minn Med. 2006 Oct; 89(10):42-4.
    View PubMed
  243. Mateen F, Jatoi A. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Clin Nutr. 2006 Oct; 25(5):711-5. Epub 2006 Jul 25.
    View PubMed
  244. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4 (4):143-52
    View PubMed
  245. Patiyil S, Chan SN, Jatoi A. New agents, new rashes: an update on skin complications from cancer chemotherapy. Curr Oncol Rep. 2006 Jul; 8 (4):269-74
    View PubMed
  246. Chan SN, Okuno SH, Jatoi A. Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol. 2006 May; 1(4):335-8.
    View PubMed
  247. Giordano KF, Jatoi A, Stella PJ, Foster N, Tschetter LK, Alberts SR, Dakhil SR, Mailliard JA, Flynn PJ, Nikcevich DA, North Central Cancer Treatment Group. Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Apr; 17 (4):652-6 Epub 2006 Feb 23
    View PubMed
  248. Jatoi A, Murphy BR, Foster NR, Nikcevich DA, Alberts SR, Knost JA, Fitch TR, Rowland KM Jr, North Central Cancer Treatment Group. Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group. Ann Oncol. 2006 Jan; 17 (1):29-34 Epub 2005 Nov 22
    View PubMed
  249. Jatoi A, Foster N, Wieland B, Murphy B, Nikcevich D, LaPlant B, Palcic MM, Baracos V. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis Esophagus. 2006; 19: (4)241-7.
    View PubMed
  250. McKian KP, Miller RC, Cassivi SD, Jatoi A. Curing patients with locally advanced esophageal cancer: an update on multimodality therapy. Dis Esophagus. 2006; 19: (6)448-53.
    View PubMed
  251. Jatoi A, Hillman S, Stella P, Green E, Adjei A, Nair S, Perez E, Amin B, Schild SE, Castillo R, Jett JR, North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005 Dec 20; 23(36):9113-9.
    View PubMed
  252. Jatoi A, Giordano KF, Nguyen PL, Sloan J, Hartmann LC. Targeting and palliating malignant ascites: an overview of an upcoming clinical trial from the north central cancer treatment group. Support Cancer Ther. 2005 Oct 1; 3(1):59-62.
    View PubMed
  253. Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution. Lung Cancer. 2005 Aug; 49(2):209-15. Epub 2005 Apr 13.
    View PubMed
  254. Jatoi A. Omega-3 fatty acid supplements for cancer-associated weight loss. Nutr Clin Pract. 2005 Aug; 20 (4):394-9
    View PubMed
  255. Giordano KF, Jatoi A. The cancer anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep. 2005 Jul; 7 (4):271-6
    View PubMed
  256. Jatoi A. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome? Crit Rev Oncol Hematol. 2005 Jul; 55(1):37-43.
    View PubMed
  257. Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, Wampfler J, Finke EE, Yang P. Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer. 2005 Jul; 49(1):77-84.
    View PubMed
  258. Schild SE, Stella PJ, Brooks BJ, Mandrekar S, Bonner JA, McGinnis WL, Mailliard JA, Krook JE, Deming RL, Adjei AA, Jatoi A, Jett JR. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly. Cancer. 2005 Jun 1; 103(11):2349-54.
    View PubMed
  259. Jatoi A, Alberts SR, Foster N, Morton R, Burch P, Block M, Nguyen PL, Kugler J, North Central Cancer Treatment Group. Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group. Support Care Cancer. 2005 Jun; 13 (6):381-6 Epub 2005 Mar 10
    View PubMed
  260. Joque L, Jatoi A. Total parenteral nutrition in cancer patients: why and when? Nutrition in Clinical Care. 2005 Apr-Jun; 8(2):89-92.
    View PubMed
  261. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer. 2005 Feb 15; 103(4):863-8.
    View PubMed
  262. Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs. Support Care Cancer. 2005 Jan; 13 (1):66-9 Epub 2004 Oct 09
    View PubMed
  263. Jatoi A, Williams BA, Marks R, Nichols FC, Aubry MC, Wampfler J, Yang P. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort. Nutr Cancer. 2005; 51(1):7-12.
    View PubMed
  264. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12 (12):859-63 Epub 2004 Sept 15
    View PubMed
  265. Jatoi A, Martenson J, Mahoney MR, Lair BS, Brindle JS, Nichols F, Caron N, Nichols F, Rowland K, Tschetter L, Alberts S. Results of a planned interim toxicity analysis with trimodality therapy, including carboplatin AUC = 4, paclitaxel, 5-fluorouracil, amifostine, and radiation for locally advanced esophageal cancer: preliminary analyses and treatment recommendations from the North Central Cancer Treatment Group. Int Semin Surg Oncol. 2004 Nov 8; 1 (1):9 Epub 2004 Nov 08
    View PubMed
  266. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 Sep; 12 (9):640-4
    View PubMed
  267. Jatoi A, Podratz KC, Gill P, Hartmann LC. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer. J Support Oncol. 2004 Jul-Aug; 2(4):323-34; discussion 334-7.
    View PubMed
  268. Jatoi A, Sideras K, Nguyen PL. Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome. Support Cancer Ther. 2004 Jul 1; 1 (4):237-42
    View PubMed
  269. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15; 22(12):2469-76.
    View PubMed
  270. Young CY, Jatoi A, Ward JF, Blute ML. The effects of dietary factors on the androgen receptor and related cellular factors in prostate cancer. Curr Med Chem. 2004 Apr; 11 (7):909-23
    View PubMed
  271. Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity. Lung Cancer. 2004 Mar; 43 (3):345-53
    View PubMed
  272. Kanard A, Frytak S, Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol. 2004 Mar-Apr; 2(2):127-32; discussion 133-5, 138-40.
    View PubMed
  273. de Andrade M, Ebbert JO, Wampfler JA, Miller DL, Marks RS, Croghan GA, Jatoi A, Finke EE, Sellers TA, Yang P. Environmental tobacco smoke exposure in women with lung cancer. Lung Cancer. 2004 Feb; 43 (2):127-34
    View PubMed
  274. Jatoi A, Nguyen PL. Weight loss in lung cancer patients with refractory, metastatic disease: clinical implications and therapeutic strategies. Oncology Nutrition Connection. 2004 Spr; 12(2):1, 3-5.
  275. Jatoi A, Foster N, Johnson P, Klee G, Quevedo JF, Morton RF, Nair S, Kardinal CG, Mailliard JA. Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment Group. Dis Esophagus. 2004; 17 (4):292-6
    View PubMed
  276. Jatoi A, Ellison N, Burch PA, Quesenberry J, Shogren K, Sloan JA, Young CYF. Prostate cancer patients with maspin-negative tumors can live over a decade. Cancer Therapy. 2004; 2:173-6.
  277. Jatoi A, Foster N, Johnson P, Klee G, Quevedo J, Morton R, Nair S, Kardinal C, Mailliard J. Investigating Four "Myths" Surrounding this symptom in Patients with Metatatic Esophageal Cancer Diseases of the Esophagus. 2004; 17(4):292-6.
  278. Nguyen PL, Xu Y, Jatoi A. Myelodysplastic syndromes. Am J Clin Pathol. 2003 Dec; 120 Suppl:S25-37.
    View PubMed
  279. Jatoi A. Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine? Semin Oncol. 2003 Dec; 30 (6 Suppl 18):72-5
    View PubMed
  280. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol. 2003 Nov-Dec; 1(4):274-8.
    View PubMed
  281. Jatoi A, Stella PJ, Hillman S, Mailliard JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study. Am J Clin Oncol. 2003 Oct; 26(5):441-7.
    View PubMed
  282. Schild SE, Stella PJ, Geyer SM, Bonner JA, McGinnis WL, Mailliard JA, Brindle J, Jatoi A, Jett JR, North Central Cancer Treatment Group. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol. 2003 Sep 1; 21(17):3201-6. Epub 2003 Jul 21.
    View PubMed
  283. Jatoi A, Hillman S, Stella PJ, Mailliard JA, Sloan J, Vanone S, Cannon MW, Kutteh L, Kanard A, Jett JR. Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer. 2003 Jul; 11 (7):460-4 Epub 2003 Mar 12
    View PubMed
  284. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
    View PubMed
  285. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2003 May 1; 21(9 Suppl):79s-81s.
    View PubMed
  286. Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003 Mar 15; 97(6):1442-6.
    View PubMed
  287. Jatoi A. Why should we care about the cancer anorexia/weight loss syndrome? Oncology (Huntington). 2003 Feb; 17: (2 Suppl 2)5-6.
    View PubMed
  288. Somerfield M, Jatoi A, Nguyen PL, Kumar S, Sloan J, Loprinzi CL. Hazards of quality-of-life data for clinical decision making. J Clin Oncol. 2003; 21(9 suppl):82-3.
    View PubMed
  289. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy. 2003;102-4.
  290. Jatoi A, Hillman S, Stella P, Mailliard J, Sloan J, Vanone S, Cannon M, Kutteh L, Kanard A, Jett J. Activities of Daily Living: Exploring their Spectrum and Prognostic Impact in Older, Chemotherapy-Treated Lung Cancer Patients Supportive Care in Cancer. 2003; 7:460-464.
  291. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002 Jan 15; 20: (2)567-73.
    View PubMed
  292. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer. 2002 Jan; 10 (1):71-5
    View PubMed
  293. Jatoi A, Thomas CR Jr. Esophageal cancer and the esophagus: challenges and potential strategies for selective cytoprotection of the tumor-bearing organ during cancer treatment. Semin Radiat Oncol. 2002 Jan; 12 (1 Suppl 1):62-7
    View PubMed
  294. Jatoi A, Nguyen PL. Anorexia: Treatment options for patients with advanced cancer. Am J Cancer. 2002; 1(4):269-75.
  295. Jatoi A, Tirona MT, Cha SS, Alberts SR, Rowland KM, Morton RF, Nair S, Kardinal CG, Stella PJ, Mailliard JA, Sargen D, Goldberg RM. A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. Int J Gastrointest Cancer. 2002; 32 (2-3):115-23
    View PubMed
  296. Jatoi A, Daly BD, Hughes VA, Dallal GE, Kehayias J, Roubenoff R. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure? Ann Thorac Surg. 2001 Aug; 72(2):348-51.
    View PubMed
  297. Jatoi A, Daly BD, Kramer G, Mason JB. Folate status among patients with non-small cell lung cancer: a case-control study. J Surg Oncol. 2001 Aug; 77(4):247-52.
    View PubMed
  298. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer. 2001 Aug 1; 92 (3):629-33
    View PubMed
  299. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001 May; 4 (3):179-82
    View PubMed
  300. Jatoi A, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Williston Park). 2001 Apr; 15: (4)497-502, 508; discussion 508-10.
    View PubMed
  301. Jatoi A, Cleary MP, Tee CM, Nguyen PL. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice. Ann Nutr Metab. 2001; 45 (3):116-20
    View PubMed
  302. Jatoi A, Kumar S, Sloan JA, Nguyen PL. On appetite and its loss. J Clin Oncol. 2000 Aug; 18: (15)2930-2.
    View PubMed
  303. Clark JL, Nguyen PL, Jaszcz WB, Jatoi A, Niehans GA. Prognostic variables in male breast cancer. Am Surg. 2000 May; 66(5):502-11.
    View PubMed
  304. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am. 1999 Oct; 79 (5):1145-56
    View PubMed
  305. Jatoi A, Daly BD, Hughes V, Dallal GE, Roubenoff R. The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer. 1999 Feb; 23(2):153-8.
    View PubMed
  306. Jatoi A, Dallal GE, Nguyen PL. False-negative rates of tumor metastases in the histologic examination of bone marrow. Mod Pathol. 1999 Jan; 12(1):29-32.
    View PubMed
  307. Jatoi A, Nguyen PL. Can pathology residents be taught to perform adequate bone marrow biopsies? Acad Med. 1999; 74(4):452.
    View PubMed
  308. Jatoi A, Lennon C, O'Brien M, Booth SL, Sadowski J, Mason JB. Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients. Eur J Clin Nutr. 1998 Dec; 52(12):934-7.
    View PubMed
  309. Jatoi A, Garcia-Moliner ML, Daly BD. Parosteal osteosarcoma from a rib. Ann Thorac Surg. 1998; 65(1):265-7.
    View PubMed
  310. Camilo ME, Jatoi A, O'Brien M, Davidson K, Sokoll L, Sadowski JA, Mason JB. Bioavailability of phylloquinone from an intravenous lipid emulsion. Am J Clin Nutr. 1998; 67(4):716-21.
    View PubMed
  311. Jatoi A, Daly BD, Kramer G, Mason JB. A cross-sectional study of vitamin intake in post-operative non-small cell lung cancer patients. J Surg Oncol. 1998; 68(4):231-6.
    View PubMed
  312. Jatoi A, Jaromin R, Jennings L, Nguyen PL. Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable. Clin Lab Manage Rev. 1998; 12(4):256-60.
    View PubMed
  313. Jatoi A, Hanjosten K, Ross E, Mason JB. A prospective survey for central line skin-site colonization by the pathogen Malassezia furfur among hospitalized adults receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1997 Jul-Aug; 21(4):230-2.
    View PubMed
  314. Jatoi A, Jaromin R, Gryzbek D, Nguyen PL. Surveying technologists: a novel method for establishing productivity standards in a clinical hematology laboratory. Health Manpower Management. 1997; 23(45):167-9.
    View PubMed
  315. Ward JC, Gitlin JB, Garry DJ, Jatoi A, Luikart SD, Zelickson BD, Dahl MV, Skubitz KM. Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. Br J Haematol. 1992 May; 81(1):27-32.
    View PubMed
  316. Massouh M, Jatoi A, Gordon EM, Ratnoff OD. Heparin co-factor II activity in plasma during pregnancy and oral contraceptive use. J Lab Clin Med. 1989; 114(6):697-9.
    View PubMed